Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

Alexander Hirsch, Robin Nijveldt, Pieter A. van der Vleuten, Jan G. P. Tijssen, Willem J. van der Giessen, Rene A. Tio, Johannes Waltenberger, Jurrien M Ten Berg, Pieter A. Doevendans, Wim R. M. Aengevaeren, Jaap Jan Zwaginga, Bart J. Biemond, Albert C. van Rossum, Jan J. Piek, Felix Zijlstra

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1736-1747
JournalEuropean Heart Journal
Volume32
Issue number14
DOIs
Publication statusPublished - Jul 2011

Keywords

  • Cell therapy
  • Myocardial infarction
  • Magnetic resonance imaging
  • Left ventricular function
  • Remodelling

Cite this

Hirsch, A., Nijveldt, R., van der Vleuten, P. A., Tijssen, J. G. P., van der Giessen, W. J., Tio, R. A., Waltenberger, J., Ten Berg, J. M., Doevendans, P. A., Aengevaeren, W. R. M., Zwaginga, J. J., Biemond, B. J., van Rossum, A. C., Piek, J. J., & Zijlstra, F. (2011). Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. European Heart Journal, 32(14), 1736-1747. https://doi.org/10.1093/eurheartj/ehq449